開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
2-year (TS) most-active contract down 0.03%; 5-year (TF) down 0.08%; 10-year (T) down 0.08%; 30-year (TL) down 0.15%.
2026-08-26
2-year (TS) most-active contract down 0.03%; 5-year (TF) down 0.08%; 10-year (T) down 0.08%; 30-year (TL) down 0.15%.
返回
其他消息
2026-08-26
【期貨熱點追蹤】受美國生物燃料政策不確定性影響,美豆油期貨三日一度下跌7%,昨日美豆走強助推美豆油期貨觸底反彈,政策利空與成本提振究竟誰能佔上風?
【期貨熱點追蹤】受美國生物燃料政策不確定性影響,美豆油期貨三日一度下跌7%,昨日美豆走強助推美豆油期貨觸底反彈,政策利空與成本提振究竟誰能佔上風?
2026-08-26
Authorities in the Beijing–Tianjin–Hebei region have issued a cross‑regional work plan to strengthen the quality chain for brain‑computer interfaces (BCI). The plan backs quality R&D by chain‑lead enterprises, universities, research institutes and medical institutions and encourages joint industry‑academic‑medical projects to resolve common quality pain points and build flagship quality‑chain projects. It targets key BCI links—neural signal acquisition, decoding, control and feedback—with emphas
Authorities in the Beijing–Tianjin–Hebei region have issued a cross‑regional work plan to strengthen the quality chain for brain‑computer interfaces (BCI). The plan backs quality R&D by chain‑lead enterprises, universities, research institutes and medical institutions and encourages joint industry‑academic‑medical projects to resolve common quality pain points and build flagship quality‑chain projects. It targets key BCI links—neural signal acquisition, decoding, control and feedback—with emphasis on EEG sensing and acquisition, human‑computer interaction and typical application scenarios. Priority technologies for breakthroughs and commercialization include new dry electrodes, flexible electrodes, BCI signal‑acquisition chips, compute/decoding chips, integrated acquisition systems and high‑performance real‑time decoding algorithms.
Chat with us
, powered by
LiveChat